Correlation Between Visa and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Visa and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Novo Nordisk AS, you can compare the effects of market volatilities on Visa and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Novo Nordisk.
Diversification Opportunities for Visa and Novo Nordisk
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Visa and Novo is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Visa i.e., Visa and Novo Nordisk go up and down completely randomly.
Pair Corralation between Visa and Novo Nordisk
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.43 times more return on investment than Novo Nordisk. However, Visa Class A is 2.32 times less risky than Novo Nordisk. It trades about 0.12 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.08 per unit of risk. If you would invest 26,555 in Visa Class A on September 25, 2024 and sell it today you would earn a total of 5,167 from holding Visa Class A or generate 19.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 99.21% |
Values | Daily Returns |
Visa Class A vs. Novo Nordisk AS
Performance |
Timeline |
Visa Class A |
Novo Nordisk AS |
Visa and Novo Nordisk Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Visa and Novo Nordisk
The main advantage of trading using opposite Visa and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
Novo Nordisk vs. Vertex Pharmaceuticals Incorporated | Novo Nordisk vs. Moderna | Novo Nordisk vs. BIONTECH SE DRN | Novo Nordisk vs. BeiGene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |